ATC code L02: Difference between revisions
CSV import |
CSV import |
||
| Line 61: | Line 61: | ||
[[Category:ATC codes|L02]] | [[Category:ATC codes|L02]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 03:08, 17 March 2025
| ATC codes |
|---|
| L Antineoplastic and immunomodulating agents |
| L01 Antineoplastic agents |
| L02 Endocrine therapy |
| L03 Immunostimulants |
| L04 Immunosuppressants |
|
A
B
C
D
G
H
QI
J
L
M
N
P
R
S
V
|
ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>
ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.
</ref><ref>
ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.
</ref> Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.<ref>
ATC/DDD Index 2022
- code L02(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.
</ref>
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL02.<ref>
ATCvet Index 2022
- code QL02(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.
</ref>
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
[edit]
L02AA Estrogens[edit]
- L02AA01 Diethylstilbestrol
- L02AA02 Polyestradiol phosphate
- L02AA03 Ethinylestradiol
- L02AA04 Fosfestrol
L02AB Progestogens[edit]
- L02AB01 Megestrol
- L02AB02 Medroxyprogesterone
- L02AB03 Gestonorone
L02AE Gonadotropin-releasing hormone analogues[edit]
- L02AE01 Buserelin
- L02AE02 Leuprorelin
- L02AE03 Goserelin
- L02AE04 Triptorelin
- L02AE05 Histrelin
- L02AE51 Leuprorelin and bicalutamide
L02AX Other hormones[edit]
[edit]
L02BA Anti-estrogens[edit]
- L02BA01 Tamoxifen
- L02BA02 Toremifene
- L02BA03 Fulvestrant
L02BB Anti-androgens[edit]
- L02BB01 Flutamide
- L02BB02 Nilutamide
- L02BB03 Bicalutamide
- L02BB04 Enzalutamide
- L02BB05 Apalutamide
L02BG Aromatase inhibitors[edit]
- L02BG01 Aminogluthetimide
- L02BG02 Formestane
- L02BG03 Anastrozole
- L02BG04 Letrozole
- L02BG05 Vorozole
- L02BG06 Exemestane
[edit]
- L02BX01 Abarelix
- L02BX02 Degarelix
- L02BX03 Abiraterone
References[edit]
<references group="" responsive="1"></references>
| Estrogens and antiestrogens | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Progestogens and antiprogestogens | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| GnRH and gonadotropins | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|